A synthetic peptide for use as a blocking control in assays to test for specificity of BRD7 antibody, Alternative Names: BRD7 control peptide, BRD7 antibody Blocking Peptide, Anti-BRD7 Blocking Peptide, bromodomain containing 7 Blocking Peptide, BP75 Blocking Peptide, CELTIX1 Blocking Peptide, NAG4 Blocking Peptide, BRD7, BRD-7, BRD 7, BRD-7 Blocking Peptide, BRD 7 Blocking Peptide
BRD7
Reaktivität: Human
Wirt: Synthetic
BP, IHC, WB
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
BRD7
(Bromodomain Containing 7 (BRD7))
Hintergrund
BRD7 is an activator of the Wnt signaling pathway in a DVL1-dependent manner by negatively regulating the GSK3B phosphotransferase activity. It induces dephosphorylation of GSK3B at 'Tyr-216'.